Relevant to CRC, mutations in PKD1 have been shown to modulate the activity of the WNT/CTNNB1 and other pro-growth signaling pathways in the kidney, although the mechanism of interaction is not incompletely understood, and distinct assay systems have yielded conflicting results [14, 15]. This evidence concerns the gene PKD1 and colorectal carcinoma.